David H. LaForge

The HOPE (Heart Outcomes Prevention Evaluation) Study: The design of a large, simple randomized trial of an angiotensin converting enzyme inhibitor (ramipril) and vitamin E in patients at high risk of cardiovascular events

F Mindlen, Roberto Nordaby, M I Soto Ruiz et al. · Queensland's institutional digital repository (The University of Queensland) · 1996 · 154 citations

Non-pharmacological Intervention, Preventive Medicine, Cardiovascular Disease +10

Novacor Left Ventricular Assist System Long-Term Performance: Comparison of Clinical Experience with Demonstrated In Vitro Reliability

Dereck Wheeldon, David H. LaForge, James Lee et al. · ASAIO Journal · 2002 · 36 citations

Initial Clinical Experience with a Wearable Controller for the Novacor Left Ventricular Assist System

Phillip J. Miller, T. Juergen Billich, David H. LaForge et al. · ASAIO Journal · 1994 · 31 citations

In vitro and in vivo testing of a totally implantable left ventricular assist system.

Jassawalla Js, H Chen, Lee J et al. · PubMed · 1989 · 17 citations

Heart Failure, Engineering, Device Therapy +16